Jefferies sees three-bagger in Axovant Sciences in premarket analyst action

|By:, SA News Editor

Taiwan Liposome (TLC) initiated with Buy rating at Janney Montgomery.

Argenx (NASDAQ:ARGX) initiated with Buy rating and $154 (51% upside) price target at Goldman Sachs. Shares up 2% premarket.

Nightstar Therapeutics (NASDAQ:NITE) initiated with Overweight rating and $28 (138% upside) price target at Barclays.

Axovant Sciences (NASDAQ:AXON) upgraded to Buy with a $3 (197% upside) price target at Jefferies. Shares up 14% premarket.

Repligen (NASDAQ:RGEN) upgraded to Buy at C.L. King.

Tenet Healthcare (NYSE:THC) downgraded to Neutral with a $25 (18% upside) price target at Baird. Shares down 6% premarket.

Centene (NYSE:CNC) removed from Conviction Buy list at Goldman. Shares down 8% on court ruling potentially invaliding Obamacare.

Zealand Pharma A/S (NASDAQ:ZEAL) downgraded to Neutral at Goldman. Shares down 2%.

Subscribe for full text news in your inbox